Hypertensive Emergency With Microangiopathy in Systemic Sclerosis
A 52-year-old woman with diffuse cutaneous systemic sclerosis diagnosed 3 years ago presents with 4 days of headaches, dyspnea, and decreased urine output. BP 188/110 mmHg, HR 96, bibasilar crackles. Labs: creatinine 2.6 mg/dL (baseline 0.8), BUN 48, potassium 5.4, bicarbonate 20, hemoglobin 9.8 g/dL, platelets 88,000/µL, LDH 480 U/L, haptoglobin 32 mg/dL, schistocytes 2+. Urine protein-to-creatinine ratio 0.9 g/g; urinalysis shows 2+ blood, few red cells, no casts. ADAMTS13 activity 45% (pending). She is on prednisone 20 mg daily for arthritis. She has no fever, and blood cultures are negative. The team considers plasma exchange for possible TTP versus ACE inhibitor therapy for scleroderma renal crisis.
1. How do you distinguish scleroderma renal crisis from TTP, and what is the immediate treatment?
Read the worked answer
Scleroderma renal crisis is the more likely diagnosis: diffuse cutaneous disease, new severe hypertension, rapidly rising creatinine, microangiopathic hemolysis, and bland urine. TTP is less likely because renal injury is usually mild, ADAMTS13 is not below 10%, and neurologic symptoms are less prominent; however, ADAMTS13 should be sent before plasma exchange. Do not wait for the result to start an ACE inhibitor. Captopril 6.25 mg orally, titrated rapidly to 25-50 mg three times daily, is first-line. The creatinine may rise further; continue the ACE inhibitor unless hypotension occurs. Plasma exchange is not indicated for scleroderma renal crisis and may delay ACE inhibition. Avoid steroids if possible because they are associated with scleroderma renal crisis.
2. What are the key management pitfalls in the first 72 hours?
Read the worked answer
Pitfalls include stopping the ACE inhibitor because creatinine rises, which worsens renal outcome; using beta-blockers as first-line, which may worsen Raynaud and do not treat the renal crisis; and giving large volumes for oliguria, which precipitates pulmonary edema. If the patient needs dialysis, continue the ACE inhibitor. Taper prednisone as quickly as possible. Monitor blood pressure closely and aim for gradual normalization rather than abrupt hypotension. Look for pericardial effusion and pulmonary hypertension. The ADAMTS13 result should guide plasma exchange only if it is below 10%.